Article Text

Download PDFPDF
Publication rates of podium presentations at the Society of Gynecologic Oncology (SGO) annual meetings
  1. Katherine Jane Chua1,
  2. Samira Moughrabi2,
  3. Danielle Glassman3,
  4. Samer Habib4,
  5. Eric Singer5 and
  6. Eugenia Girda6
  1. 1Gynecology Oncology, University of California Davis Health System, Sacramento, California, USA
  2. 2California State University Dominguez Hills School of Nursing, Carson, California, USA
  3. 3Obstetrics and Gynecology, Rutgers Robert Wood Johnson Medical School New Brunswick, New Brunswick, New Jersey, USA
  4. 4The University of Texas Southwestern Medical Center, Dallas, Texas, USA
  5. 5The Ohio State University Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, Ohio, USA
  6. 6Gynecology Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA
  1. Correspondence to Dr Katherine Jane Chua, University of California Davis Health System, Sacramento, CA 95817, USA; katherine.chua168{at}


Objectives Our study aimed to determine the publication rates of podium presentations from the 2017 and 2018 Society of Gynecologic Oncology (SGO) Annual Meetings; and to examine rates and predictors of oral presentations that resulted in publication.

Methods We reviewed podium presentations given at the 2017 and 2018 SGO Annual Meetings. Abstracts were evaluated for publication from January 1, 2017 to March 30, 2020 and January 1, 2018 to June 30, 2021, respectively, to allow for a 3 year period of publication.

Results In 2017 and 2018, 43 of 75 (57.3%) and 47 of 83 (56.6%) podium presentations were published within 3 years, respectively. No significant difference was found between the mean time to publication within 3 years (13.0 months vs 14.1 months for 2017 and 2018, respectively; p=0.96). Similarly, the mean difference of journal impact factors between both years did not reach significance (6.57 and 10.7 for 2017 and 2018, respectively; p=0.09). The median impact factor (IF) was 4.54 (range: 40.3) and 4.62 (range: 70.7) in 2017 and 2018, respectively. Of the presentations published, 53.4% (2017) and 38.3% (2018) appeared in the journal Gynecologic Oncology. Significant positive correlations for the likelihood of publication were determined among the following: funding status (r=0.93) including funding involving National Institutes for Health (r=0.91) or pharmaceutical (r=0.95), clinical trial study design (r=0.94), and pre-clinical research (r=0.95) (all p<0.005).

Conclusions At the 2017 and 2018 SGO Annual Meetings 57% of podium presentations were published in a peer-reviewed journal within 3 years. Publication in peer-reviewed journals is crucial for timely distribution of clinical information to the medical community.

  • Miscellaneous
  • COVID-19

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text


  • Twitter @daniglassman

  • Contributors KJC is the guarantor of the study. KJC and DG collected data and contributed to the manuscript with KJC being lead on the study project. SM and SH performed statistical analysis and SM contributed to manuscript. ES and EG supervised the study protocol, data collection, and manuscript production.

  • Funding This work is supported by a grant from the National Cancer Institute (P30CA072720).

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.